スダ　サトシ   SUDA Satoshi   須田　智    所属   埼玉医科大学  医学部 国際医療センター　神経内科・脳卒中内科    職種   教授
論文種別	学術雑誌(原著)
言語種別	英語
査読の有無	査読あり
表題	Multicenter Prospective Analysis of Stroke Patients Taking Oral Anticoagulants: The PASTA Registry - Study Design and Characteristics.
掲載誌名	正式名：Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association ISSNコード：1052-3057
掲載区分	国外
巻・号・頁	28(12),104456-104456頁
著者・共著者	Satoshi Suda,Yasuyuki Iguchi,Shigeru Fujimoto,Yoshiki Yagita,Yu Kono,Masayuki Ueda,Kenichi Todo,Tomoyuki Kono,Takayuki Mizunari,Mineo Yamazaki,Takao Kanzawa,Seiji Okubo,Kimito Kondo,Nobuhito Nakajima,Takeshi Inoue,Takeshi Iwanaga,Makoto Nakajima,Ichiro Imafuku,Kensaku Shibazaki,Masahiro Mishina,Koji Adachi,Koichi Nomura,Masataka Nakajima,Hiroshi Yaguchi,Sadahisa Okamoto,Masato Osaki,Yuka Terasawa,Takehiko Nagao,Kazumi Kimura
発行年月	2019/12
概要	OBJECTIVES: The management of atrial fibrillation and deep venous thrombosis has evolved with the development of direct oral anticoagulants (DOAC), and oral anticoagulant (OAC) might influence the development or clinical course in both ischemic and hemorrhagic stroke. However, detailed data on the differences between the effects of the prior prescription of warfarin and DOAC on the clinical characteristics, neuroradiologic findings, and outcome of stroke are limited. DESIGN: The prospective analysis of stroke patients taking anticoagulants (PASTA) registry study is an observational, multicenter, prospective registry of stroke (ischemic stroke, transient ischemic attack, and intracerebral hemorrhage) patients receiving OAC in Japan. This study is designed to collect data on clinical background characteristics, drug adherence, drug dosage, neurological severity at admission and discharge, infarct or hematoma size, acute therapy including recanalization therapy or reverse drug therapy, and timing of OAC re-initiation. Patient enrollment started in April 2016 and the target patient number is 1000 patients. CONCLUSIONS: The PASTA prospective registry should identify the status of stroke patients taking OAC in the current clinical practice in Japan.
DOI	10.1016/j.jstrokecerebrovasdis.2019.104456
PMID	31676161